Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Systematic Review

Accepted on 31 Mar 2025

Global trends in resistance studies of gemcitabine and pancreatic cancer: a bibliometric and visual analysis from 2010 to 2024

in Pharmacology of Anti-Cancer Drugs

Dandan Gu
Shaoyang Huang
Kai Zhao
Xiaohong Zhang
Jinjing Zhang
Wei Xiong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564561

Original Research

Accepted on 31 Mar 2025

SUMOylation substrate encoding genesRelated Genes as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma with Functional Assessment of SAF-B2

in Pharmacology of Anti-Cancer Drugs

Xiangjun Wang
Chuanxin Yang
Yangming Liu
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1532658

Review

Accepted on 31 Mar 2025

SREBP2 as a central player in cancer progression: potential for targeted therapeutics

in Pharmacology of Anti-Cancer Drugs

Ruiqi Chen
Tianyu Chen
Xiang Li
Junfeng Yu
Min Lin
Siqi Wen
Man Zhang
Jinchi Chen
Bei Yi
Huage Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1535691

Original Research

Accepted on 31 Mar 2025

Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Jipin Li
Tao Yong
Yali Chen
Tingyu Zeng
Kaifeng Zhang
Shuping Wang
Youcheng Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1571786

Original Research

Accepted on 31 Mar 2025

Dehydroleucodine Exerts an Antiproliferative Effect on Human Burkitt's Lymphoma Daudi Cells via SLC7A11-mediated Ferroptosis

in Pharmacology of Anti-Cancer Drugs

Rui Shen
Fang Cheng
Rui Guo
Wenjing Wang
Xiaolong Yang
Yemiao CHEN
Yaokai Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572364

Review

Published on 28 Mar 2025

The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression

in Pharmacology of Anti-Cancer Drugs

Yongsheng Zhang
Yanjiao Xu
Yanping Zhang
Shoushi Wang
Mingqiang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559408

165 views

Review

Published on 28 Mar 2025

The potential of dibenzazepine carboxamides in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Nastaran Afsordeh
Safura Pournajaf
Javad Mirnajafi-Zadeh
Mohammad Hossein Pourgholami

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564911

266 views

Original Research

Published on 28 Mar 2025

Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth

in Pharmacology of Anti-Cancer Drugs

Baoyi Jiang
Jie Yang
Qingtian Huang
Wei Li
Qian Peng
Huoye Gan
Tieli Peng
Leyi Yao
Ling Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547685

188 views

Review

Published on 28 Mar 2025

Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers

in Pharmacology of Anti-Cancer Drugs

Qingmei Ye
Xiao-Zhao Zhuang
Juan Li
Xin Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1562167

264 views

Original Research

Accepted on 27 Mar 2025

Knowledge, attitudes, and practices of healthcare providers toward ADR reporting regarding thiopurine drugs for the treatment of acute lymphoblastic leukemia at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

in Pharmacology of Anti-Cancer Drugs

Eyuel Kassa
Mastewal Birhan
Mulugeta Ayalew
Aschalew Gelaw
Abdulkader Mohamedsaid Gidey
Degalem Tilahun Worku
Hiyaw Abebe
Ermias Teklehaimanot
Nega Berhane Tessemma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1486415

Mini Review

Published on 27 Mar 2025

Molecular mechanisms and signaling pathways related to brain metastasis in breast cancer

in Pharmacology of Anti-Cancer Drugs

Zhuming Liang
Yanan Mo
Yujiao Zhang
Yanjing Yu
Yinan Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1585668

277 views

Original Research

Published on 27 Mar 2025

Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy

in Pharmacology of Anti-Cancer Drugs

Hui Li
Hongliang Zhang
Wenting He

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529010

194 views

Original Research

Published on 27 Mar 2025

The characteristics of adverse reactions of three anti-prostate cancer drugs based on Vigiaccess database and bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Jianqing Wang
Jia You
Weixing Huang
Chiting Yuan
Jiangjie Chen
Feifei Wang
Wei Wang
Liwei Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570661

263 views

Review

Published on 27 Mar 2025

Recent advancement in the anticancer efficacy of the natural flavonoid scutellarin: a comprehensive review

in Pharmacology of Anti-Cancer Drugs

Deena Elsori
Pratibha Pandey
Meenakshi Verma
Nasir Vadia
R. Roopashree
Manish Vyas
L. Lakshmi
Laxmidhar Maharana
Deepak Nathiya
Mohd Saeed

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1579609

196 views

Case Report

Accepted on 26 Mar 2025

Excellent Efficacy of Trastuzumab Deruxtecan in a Patient with HER2-Positive Advanced Breast Cancer Complicated by Pulmonary Lymphangitic Carcinomatosis: A Case Report and Literature Review

in Pharmacology of Anti-Cancer Drugs

Simin Luo
Jie Chai
Lin Xiaoxiao Ding
Song Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1574286

109 views

Case Report

Accepted on 26 Mar 2025

Transformative Potential of Trastuzumab Deruxtecan in the First Line Treatment for Advanced HER2-Mutated Lung Adenocarcinoma: A Case Report and Clinical Insights

in Pharmacology of Anti-Cancer Drugs

Guanbin Huang
Tongtong Xia
Dongxiao Yang
Muwen Lin
Yiping Luo
Yuchan Li
Hualin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1564834